Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
THYMVITAL is a dietary supplement developed and marketed by biosyn Arzneimittel GmbH, specifically formulated to support immune system function and provide antioxidant protection. It is a combination product containing thymus extract (derived from calf thymus), zinc (as zinc gluconate), and selenium (as sodium selenite pentahydrate). The product features a specialized enteric coating (galenic formulation) designed to protect the sensitive thymus peptides from degradation by gastric acid, ensuring their release and absorption in the small intestine. Zinc and selenium are included for their roles as essential cofactors that contribute to normal immune function and the protection of cells from oxidative stress. It is typically administered as a once-daily oral capsule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on THYMVITAL.